Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 09, 2015 5:11 AM ET

Life Sciences Tools and Services

Company Overview of Aphios Corporation

Company Overview

Aphios Corporation develops enabling biotechnology and nanotechnology drug delivery platforms. It also manufactures quality-of-life medicines for health maintenance; research chemicals for standards; and active pharmaceutical ingredients for pharmaceuticals. The company’s therapeutic products include Zindol, an enhanced ginger product; APH-0703, a potent protein kinase C (PKC) activator; APH-0812, a combination therapy consisting of PKC modulators with or without HDAC inhibitors; AMPI-109, a nontoxic Vitamin D3 derivative for hormone refractory prostate cancer; APH-0911, a nanotechnology formulation of Taxotere prodrug with sugar side chain that improves the oral bioavailability of water-sol...

3-E Gill Street

New Boston Park

Woburn, MA 01801

United States

Founded in 1993





Key Executives for Aphios Corporation

Founder, Chairman of The Board, Chief Executive Officer and President
Chief Financial Officer
Compensation as of Fiscal Year 2015.

Aphios Corporation Key Developments

Aphios Completes Enrollment in Phase I/II Clinical Trial Towards an HIV Cure

Aphios Corporation announced that clinical trial enrollment has been completed for a Phase I/II clinical trial on APH-0812 for HIV latency in Madrid, Spain. Aphios is collaborating with researchers at the University of Córdoba, Córdoba, Spain and clinical investigators led by Dr. Santiago Moreno at the Department of Infectious Diseases, Ramón y Cajal Hospital, Madrid, Spain to conduct a Phase I/II randomized, placebo-controlled clinical trial initially on the PKC component (Bryostatin-1) of APH-0812 in cART-treated HIV patients in Spain.

Aphios Corporation Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015

Aphios Corporation Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.

Similar Private Companies By Industry

Company Name Region
Admera Health, LLC United States
Proven Process Medical Devices, Inc. United States
Boston Biomedical Associates LLC United States
Drik LLC United States
Targeted Molecular Diagnostics, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aphios Corporation, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at